Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome
- PMID: 16408189
- DOI: 10.1007/s00404-005-0112-0
Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome
Abstract
Ovarian hyperstimulation syndrome (OHSS) is a severe complication of ovarian stimulation. No reliable test exists to predict the syndrome. The objective of the present prospective observational study was to examine vascular endothelial growth factor (VEGF) secretion after human chorionic gonadotropin (hCG) administration in the luteal phase of a spontaneous cycle of women with a history of severe OHSS. Five women with a history of severe OHSS were administered 250 mug recombinant hCG intravenously on day 21 of a spontaneous menstrual cycle. Plasma samples were collected at regular intervals from 15 min before hCG to 6 h thereafter and the free VEGF plasma concentrations were determined. Plasma levels of free VEGF remained at the lower detection limit of the assay throughout the observational period. Women with previous severe OHSS do not show a significant short-time response of VEGF secretion upon hCG administration. No evidence was found to support the notion that women inclined to develop a severe form of the syndrome after ovarian stimulation could possibly be identified by the VEGF short-time secretory response to exogenous hCG in the luteal phase of a spontaneous cycle.
Similar articles
-
Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.Hum Reprod. 2006 May;21(5):1260-5. doi: 10.1093/humrep/dei475. Epub 2006 Jan 26. Hum Reprod. 2006. PMID: 16439507 Clinical Trial.
-
[The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jul;34(3):565-7. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003. PMID: 12910723 Chinese.
-
Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.Chin Med J (Engl). 2008 Dec 5;121(23):2434-9. Chin Med J (Engl). 2008. PMID: 19102964
-
New insights in mechanisms for development of ovarian hyperstimulation syndrome.Coll Antropol. 2010 Sep;34(3):1139-43. Coll Antropol. 2010. PMID: 20977119 Review.
-
Prevention and management of ovarian hyperstimulation syndrome.Ann N Y Acad Sci. 2006 Dec;1092:247-64. doi: 10.1196/annals.1365.021. Ann N Y Acad Sci. 2006. PMID: 17308149 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
